Officer Patrick Finn Files Intent to Sell $3.56M in Stock Amidst 52-Week Highs
Summary
Officer Patrick Finn has filed a Form 144 to sell approximately $3.56 million worth of common stock, continuing a trend of insider sales while the stock trades near its 52-week high.
Key Events
-
Officer Files Intent to Sell
Officer Patrick Finn has filed a Form 144, indicating a proposed sale of 68,967 shares of common stock.
-
Significant Proposed Sale Value
The aggregate market value of the shares intended to be sold is approximately $3,562,414.66.
-
Follows Recent Insider Sales
This filing follows previous sales by Patrick Finn totaling $1,474,907.42 over the past three months, including a Form 144 filed on February 13, 2026, indicating a pattern of insider distribution.
-
Timing Near 52-Week Highs
The intent to sell comes as Twist Bioscience's stock is trading near its 52-week high, potentially signaling an effort to realize gains.
Analysis
Officer Patrick Finn's filing of a Form 144 indicates an intent to sell a significant block of shares, valued at over $3.5 million. This proposed sale, following other recent dispositions by the same officer, suggests a pattern of insider selling. The timing is notable as the company's stock is currently trading near its 52-week high, which could imply the officer is locking in gains. Investors should monitor subsequent Form 4 filings to confirm the actual execution of these sales and assess the ongoing insider sentiment.
At the time of this filing, TWST was trading at $52.88 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $3.2B. The 52-week trading range was $23.30 to $53.42. This filing was assessed with negative market sentiment and an importance score of 7 out of 10.